BNVI.OB Insider Trading Activity and SEC Form 4 Filings
BNVI.OB insider trading summary
No open-market insider purchases or sales of Bionovo Inc (BNVI.OB) have been reported on SEC Form 4 in the past 12 months.
Latest BNVI.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 13, 2010 | Isaac Cohen | Chairman and CEO | Buy | $15K (15,000 @ $1.01) |
| Feb 23, 2010 | Mary Tagliaferri | VP, CRO, Treasurer, Secretary | Buy | $10K (17,000 @ $0.56) |
| Oct 26, 2009 | David Naveh | Director | Buy | $4K (10,000 @ $0.41) |
| Jun 22, 2007 | Michael D Vanderhoof | Director | Buy | $20K (5,100 @ $4.00) |
| Jun 22, 2007 | Michael D Vanderhoof | Director | Buy | $5K (1,300 @ $4.02) |
| Jun 22, 2007 | Michael D Vanderhoof | Director | Buy | $4K (1,100 @ $4.03) |
| Jun 22, 2007 | Michael D Vanderhoof | Director | Buy | $20K (4,900 @ $4.10) |
| Jun 22, 2007 | Michael D Vanderhoof | Director | Buy | $10K (2,600 @ $4.03) |
| Mar 1, 2007 | David Naveh | Director | Sell | $168K (30,000 @ $5.59) |
| Jan 29, 2007 | Isaac Cohen | Chairman, President, CEO, CSO | Sell | $400K (250,000 @ $1.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.